Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Studying both sexes: a guiding principle for biomedicine.
GEMS Project: A Platform to Investigate Multiple Sclerosis Risk.
Visualization of myelination in GFP-transgenic zebrafish.
Long-term use of glatiramer acetate by 11 pregnant women with multiple sclerosis: a retrospective, multicentre case series.
Gene Expression & Signaling in the Immune System
Vitamin D receptor-retinoid X receptor heterodimer signaling regulates oligodendrocyte progenitor cell differentiation.
Reversible pulmonary artery hypertension in association with interferon-beta therapy for multiple sclerosis.
NICE recommends new treatment option for multiple sclerosis (Dimethyl fumarate)
Glatiramer acetate in primary progressive multiple sclerosis: results of a multinational, multicenter, double-blind, placebo-controlled trial.
HLA alleles as biomarkers of high-titre neutralising antibodies to interferon-β therapy in multiple sclerosis.
Opinion: Sex inclusion in basic research drives discovery.
Regulatory CD56(bright) natural killer cells mediate immunomodulatory effects of IL-2Ralpha-targeted therapy (daclizumab) in multiple sclerosis.
Daclizumab HYP versus Interferon Beta-1a in Relapsing Multiple Sclerosis.
Semen quality of 4480 young cancer and systemic disease patients: baseline data and clinical considerations.
A longitudinal uncontrolled study of cerebral gray matter volume in patients receiving natalizumab for multiple sclerosis.
Clinical, environmental, and genetic determinants of multiple sclerosis in children with acute demyelination: a prospective national cohort study.
Association of Immunotherapies With Outcomes in Relapsing-Remitting Multiple Sclerosis.
Teva Pharmaceutical Industries Limited's CEO Discusses Q1 2012 Results - Earnings Call Transcript
Interplay between exercise and dietary fat modulates myelinogenesis in the central nervous system.
PHENYTEK®* Capsules (extended phenytoin sodium capsules, USP)
Patterns of Treatment Switching in Multiple Sclerosis Therapies in US Patients Active on Social Media: Application of Social Media Content Analysis to Health Outcomes Research.
FTY720 impairs CD8 T-cell function independently of the sphingosine-1-phosphate pathway.
Limit cycle oscillations in standing human posture.
Gene expression analysis reveals functional pathways of glatiramer acetate activation.
Risk of natalizumab-associated progressive multifocal leukoencephalopathy.
Pages
« first
‹ previous
…
96
97
98
99
100
101
102
103
104
…
next ›
last »